Bud Genius Receives Funding Commitment from Angel Investor
August 21 2014 - 8:37AM
Business Wire
Funding to establish Bud Genius’ (OTC:RIGH) new subsidiary,
called Genius Biotech Corporation, was received last week, and an
angel investment group has committed to putting in initial capital
for the new project, which will more than double the scope of the
company's business.
Regarding the group of angel investors who have committed to
putting in capital, Stanz said, “We think it was a great deal for
the investors who put money into the project, and also will be a
great deal for us. They were very demanding about wanting full
reporting, audits, and internal financial controls. All of our
shareholders will benefit from this."
The funding commitment will pay for certain company expenses to
be announced after paperwork has been signed.
About Bud GeniusAn early leader in an industry that many
are speculating will grow, Bud Genius is one of the first
established analytical cannabis laboratories in the United States.
Bud Genius was launched to bring vendors together with doctors,
patients, and dispensaries that require certified products held to
demanding standards. Bud Genius has a vision to expand across the
US and abroad serving as the beacon of quality for medical cannabis
and adult-use marijuana through the formation of regional
laboratories. Certification, data collection, and online reports
are the measure by which the company gains.
For more information please visit:http://www.BudGenius.com
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
Bud GeniusAngel Stanz, Chief Executive
Officer855-723-32837PR@BudGenius.com
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Aug 2024 to Sep 2024
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Sep 2023 to Sep 2024